Matthew Woodruff

Matthew Woodruff is an Instructor of Human Immunology at Emory University. He received a BS in biotechnology in 2008 from the Rochester Institute of Technology (RIT). Immediately following, he attended Harvard University as a doctoral candidate in immunology, graduating in 2014 with a thesis describing the earliest phases of immune response following influenza vaccination. In 2014, he pursued a postodoctoral fellowship at Emory University, again studying the early phases of immune response (specifically antibody selection). He published that work in 2018, and transitioned into a human immunology lab under Dr. Iñaki Sanz, specializing in the study of autoimmune diseases. Since the start of the COVID-19 pandemic, he has refocused almost entirely on studying the immune responses in patients with severe COVID-19.

Here are answers from immunologist Matthew Woodruff to five big questions about the FDA's single-shot vaccine decision.
By Matthew Woodruff
COVID Omicron variant
The data is clear: COVID-19 poses a significant threat to both the mother and child, and vaccination can help mitigate that risk, writes immunologist Matthew Woodruff.
By Matthew Woodruff
pregnant woman getting vaccine
In recommending against boosters for the general public, the committee cited reasons such as lack of sufficient safety data in younger age groups and indications that initial doses still seem to be provide robust protection against severe illness.
By Matthew Woodruff
(Christian County Health Department photo)
Here are answers from immunologist Matthew Woodruff to five big questions about the FDA's single-shot vaccine decision.
By Matthew Woodruff
COVID Omicron variant
The data is clear: COVID-19 poses a significant threat to both the mother and child, and vaccination can help mitigate that risk, writes immunologist Matthew Woodruff.
By Matthew Woodruff
pregnant woman getting vaccine
In recommending against boosters for the general public, the committee cited reasons such as lack of sufficient safety data in younger age groups and indications that initial doses still seem to be provide robust protection against severe illness.
By Matthew Woodruff
(Christian County Health Department photo)